Vt. to get $95K in drug settlement
MONTPELIER, Vt. - October 5, 2010 -- Vermont will receive $95,000 as part of a multistate settlement with a subsidiary of pharmaceutical giant Johnson & Johnson accused of promoting a drug for uses not approved by the Food and Drug Administration.
The $75 million settlement with Titusville, N.J.-based Ortho-McNeil-Janssen Pharmaceuticals Inc., involves all 50 states, the District of Columbia and the federal government.
The agreement announced Monday resolves allegations that the company promoted topiramate, an antiepileptic and migraine prevention drug marketed as Topamax 5/8, for uses not approved by the FDA, such as for bipolar disorder and drug and alcohol dependency.
johnson & johnson, vermont, new jersey, business/finance
- Police officers narrowly escape bullets in North Philly 4 min ago
- AccuWeather: Friday Clouds and SE Rain
- Get the 6abc StormTracker app
- WATCH: Action News Online
- Shots fired into a Philadelphia firehouse
- 3 Phila. schools closed Friday, staff relocated
- How to safeguard your computer against kidnappers
- Retired Philly cop charged with assaulting teen
- Police: Gloucester Co. woman's death a homicide
- Police search for missing Philadelphia couple
- Photos: Suspects wanted by Philadelphia Police
- Resident return to assess damage from Ewing explosion
- K9 unit leads police to burglary suspect in Medford
- Upper Darby cop charged with DUI in hit-and-run